FDA
approval
· 2018-08-31
FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application for AMNESTEEM (isotretinoin) submitted by Mylan Pharmaceuticals. This action approves changes to the approved isotre…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMNESTEEM (ISOTRETINOIN)